Patent · US Active

Crystalline modifications of N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride and N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts

US10981864B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Axel Becker · Altrip, DE
Gilmary Gallon · Le Puy-en-Velay, FR
Christoph Saal · Otzberg, DE
Clemens Kuehn · Darmstadt, DE

Key dates

Filing date	Jan 27, 2017
Grant date	Apr 20, 2021
Priority date	—
Expiry date	Mar 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel crystalline modifications of N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine hydrochloride, novel N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine salts and their crystalline modifications and processes of manufacturing and pharmaceutical formulations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.